Two Sigma Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Sell |
|
|||||
|
2025
Q1 | $1.09M | Buy |
|
|||||
|
2024
Q4 | $282K | Buy |
|
|||||
|
2024
Q3 | $212K | Sell |
|
|||||
|
2024
Q2 | $819K | Sell |
|
|||||
|
2024
Q1 | $4.89M | Sell |
|
|||||
|
2023
Q4 | $6.57M | Buy |
|
|||||
|
2023
Q3 | $5.41M | Sell |
|
|||||
|
2023
Q2 | $8.4M | Sell |
|
|||||
|
2023
Q1 | $11.2M | Buy |
|
|||||
|
2022
Q4 | $7.7M | Buy |
|
|||||
|
2022
Q3 | $3.29M | Buy |
|
|||||
|
2022
Q2 | $414K | Sell |
|
|||||
|
2022
Q1 | $992K | Buy |
|
|||||
|
2021
Q4 | $650K | Buy |
|
|||||
|
2021
Q3 | $341K | Sell |
|
|||||
|
2021
Q2 | $2.67M | Sell |
|
|||||
|
2021
Q1 | $6.09M | Buy |
|
|||||
|
2020
Q4 | $3.6M | Sell |
|
|||||
|
2020
Q3 | $5.06M | Sell |
|
|||||
|
2020
Q2 | $9.88M | Buy |
|
|||||
|
2020
Q1 | $6.83M | Buy |
|
|||||
|
2019
Q4 | $3.07M | Sell |
|
|||||
|
2019
Q3 | $3.57M | Sell |
|
|||||
|
2019
Q2 | $10.9M | Buy |
|
|||||
|
2019
Q1 | $8.14M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $694K | Buy |
|
|||||
|
2018
Q1 | $321K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $793K | Buy |
|
|||||
|
2017
Q1 | $570K | Buy |
|
|||||
|
2016
Q4 | $452K | Buy |
|
|||||
|
2016
Q3 | $401K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $442K | Buy |
|